Premium
[P2–263]: GRAPHICAL NETWORK ANALYSES INFORMS PET Aβ‐AMYLOID BIOMARKER DISCOVERY VIA QUANTIFICATION OF INDIVIDUAL PEPTIDE CONNECTIONS
Author(s) -
Doecke James D.,
Whittle Emma,
Villemagne Victor LL.,
Masters Colin L.,
Roberts Blaine R.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - French
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.916
Subject(s) - peptide , amyloid (mycology) , biomarker , computational biology , apolipoprotein b , serum amyloid a , amyloid beta , biomarker discovery , pathology , proteomics , biology , chemistry , biochemistry , medicine , immunology , gene , cholesterol , inflammation
Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM), Institut de la M emoire et de la Maladie d’Alzheimer (IM2A), Paris, France; University of Pisa, Pisa, Italy; University of Rome Tor Vergata, Rome, Italy; Athinoula A. Martinos Center for Biomedical Imaging, Boston, MA, USA; Laboratory of Alzheimer’s Neuroimaging and Epidemiology, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; AXA Research Fund & UPMC Chair, Paris, France; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, M€olndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, M€olndal, Sweden; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; University College London, London, United Kingdom; Laboratoire de Biochimie, AP-HP, Hôpital de la Piti e-Salpêtri ere, Paris, France; Service de Biochimie M etabolique, Hôpital Piti e-Salpêtri ere, Paris, France; Sorbonne Universit es, UPMC Univ Paris 06, CNRS, INSERM, Laboratoire d’Imagerie Biom edicale, F-75013, Paris, France; Sorbonne Universit es, Universit e Pierre et Marie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM), Institut de la M emoire et de la Maladie d’Alzheimer (IM2A), Paris, France; AXA Research Fund & UPMC Chair, Sorbonne Universit es, Universit e Pierre etMarie Curie (UPMC) Paris 06, Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM), Institut de la M emoire et de la Maladie d’Alzheimer (IM2A), Paris, France. Contact e-mail: filippo.baldacci@unipi.it